An international, multicenter, randomized, double-blind phase III study of maintenance belagenpumatucel-l in non-small cell lung cancer (NSCLC): Updated analysis of patients enrolled within 12 weeks of completion of chemotherapy.
Lyudmila Bazhenova
Research Funding - NovaRX
Giuseppe Giaccone
No relevant relationships to disclose
John J. Nemunaitis
No relevant relationships to disclose
Erzsébet Juhász
No relevant relationships to disclose
Rodryg Ramlau
No relevant relationships to disclose
Michel M van den Heuvel
No relevant relationships to disclose
Rohit Lal
Research Funding - NovaRX
David Dunlop
No relevant relationships to disclose
Edward B. Garon
Research Funding - NovaRX
Quincy S. Chu
No relevant relationships to disclose
Minish Mahendra Jain
No relevant relationships to disclose
Ewa Carrier
No relevant relationships to disclose
Steven Moses
Employment or Leadership Position - NovaRX
Daniel Shawler
Employment or Leadership Position - NovaRX
Habib Fakhrai
Employment or Leadership Position - NovaRX
Stock Ownership - NavaRx